Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Cell Culture Medium
- Cell Culture Reagent
- Cell Function Assay
- Cell Health Detection Kit
- Isolation Kit
- Others
- Primary Cell
- Serum
- Service
- Transfection Reagent
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Guyana
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Luxembourg
- Madagascar
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Niger
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Russian Federation
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 30,495 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Sulfobetaine modification of poly (D, L-lactide-co-glycolic acid) nanoparticles enhances mucus permeability and improves bioavailability of orally delivered liraglutide (2024-02-01)
Journal: JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2024) IF: 5Products Cited: Fetal Bovine Serum, DMEM(High glucose) -
Multi-omics comprehensive analyses of programmed cell death patterns to regulate the immune characteristics of head and neck squamous cell carcinoma (2024-01-18)
Journal: Translational Oncology (2024) IF: 5Products Cited: DMEM(High glucose), Fetal Bovine Serum -
Tartaric acid ameliorates experimental non-alcoholic fatty liver disease by activating the AMP-activated protein kinase signaling pathway (2024-05-23)
Journal: EUROPEAN JOURNAL OF PHARMACOLOGY (2024) IF: 5Products Cited: DMEM/F12, with HEPES Medium, Penicillin-Streptomycin Solution, 100 × -
Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer (2024-03-06)
Journal: Translational Oncology (2024) IF: 5Products Cited: RPMI-1640, Fetal Bovine Serum -
Protective effects of Prussian blue nanozyme against sepsis-induced acute lung injury by activating HO-1 (2024-02-03)
Journal: EUROPEAN JOURNAL OF PHARMACOLOGY (2024) IF: 5Products Cited: Ham's F-12K -
The composition of phenolic compounds in Chinese olive (Canarium album L.) cultivars and their contribution to the anti-inflammatory properties of the cultivars (2024-02-19)
Journal: Frontiers in Nutrition (2024) IF: 5Products Cited: DMEM(High glucose) -
Gibberellic acid targeting ZBTB16 reduces NF-κB dependent inflammatory stress in sepsis-induced neuroinflammation (2024-05-24)
Journal: EUROPEAN JOURNAL OF PHARMACOLOGY (2024) IF: 5Products Cited: Penicillin-Streptomycin Solution, 100 ×, MEM Medium, BV2 (DMEM) Cell Complete Medium, Fetal Bovine Serum -
MFG-E8 induces epithelial-mesenchymal transition and anoikis resistance to promote the metastasis of pancreatic cancer cells (2024-02-29)
Journal: EUROPEAN JOURNAL OF PHARMACOLOGY (2024) IF: 5Products Cited: DMEM(High glucose), Fetal Bovine Serum -
Enhancement of Biocompatibility of High-Transparency Zirconia Abutments with Human Gingival Fibroblasts via Cold Atmospheric Plasma Treatment: An In Vitro Study (2024-07-21)
Journal: Journal of Functional Biomaterials (2024) IF: 5DOI: 10.3390/jfb15070200Products Cited: Human Gingival Fibroblast Cells -
Rituximab potentially improves clinical outcomes of CAR-T therapy for r/r B-ALL via sensitizing leukemia cells to CAR-T-mediated cytotoxicity and reducing CAR-T exhaustion (2024-04-25)
Journal: CELLULAR ONCOLOGY (2024) IF: 4.9
